Vonoprazan Fumarate API Market: Growth Dynamics and Regional Expansion in Gastrointestinal Therapy
The Vonoprazan Fumarate API Market is witnessing rapid growth as gastrointestinal disorders become increasingly prevalent. With its superior efficacy over traditional proton pump inhibitors, Vonoprazan is gaining preference among physicians for treating GERD, peptic ulcers, and H. pylori infections. Hospitals and pharmaceutical manufacturers are investing in research, ensuring wider...
0 Комментарии 0 Поделились 403 Просмотры 0 предпросмотр
Спонсоры